NATIXIS ADVISORS, L.P. – Vertex Pharmaceuticals Incorporated Transaction History
NATIXIS ADVISORS, L.P. portfolio value:
$147.20M
portfolio value
NATIXIS ADVISORS, L.P. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -15.85% | -95.77K shares | -23.04M | $289.54 | 508.42K |
| Q2 2022 | share | Decrease | -9.89% | -66.32K shares | -4.72M | $281.79 | 604.19K |
| Q1 2022 | share | Increase | +0.41% | 2.71K shares | 28.33M | $260.97 | 670.51K |
| Q4 2021 | share | Increase | +8.28% | 51.09K shares | 34.78M | $222.45 | 667.80K |
| Q3 2021 | share | Increase | +195.40% | 407.93K shares | 69.77M | $181.39 | 616.70K |
| Q2 2021 | share | Increase | +22.01% | 37.66K shares | 5.32M | $201.63 | 208.77K |
| Q1 2021 | share | Increase | +21.81% | 30.63K shares | 3.57M | $214.89 | 171.10K |
| Q4 2020 | share | Decrease | -33.12% | -69.57K shares | -23.95M | $236.34 | 140.46K |
| Q3 2020 | share | Increase | +6.64% | 13.08K shares | -22K | $272.12 | 210.04K |
| Q2 2020 | share | Increase | +26.07% | 40.73K shares | 20.00M | $290.31 | 196.95K |
| Q1 2020 | share | Increase | +12.13% | 16.90K shares | 6.66M | $237.95 | 156.22K |
| Q4 2019 | share | Increase | +0.77% | 1.06K shares | 7.08M | $218.95 | 139.32K |
| Q3 2019 | share | Increase | +6.68% | 8.66K shares | -342K | $169.42 | 138.26K |
| Q2 2019 | share | Increase | +7.09% | 8.58K shares | 1.50M | $183.38 | 129.60K |
| Q1 2019 | share | Decrease | -6.31% | -8.15K shares | 858K | $183.95 | 121.02K |
| Q4 2018 | share | Increase | +2.28% | 2.88K shares | -2.93M | $165.71 | 129.17K |
| Q3 2018 | share | Increase | +8.79% | 10.20K shares | 4.61M | $192.74 | 126.29K |
| Q2 2018 | share | Increase | +46.51% | 36.85K shares | 6.81M | $169.96 | 116.08K |
| Q1 2018 | share | Increase | 0.00% | 79.23K shares | 12.91M | $162.98 | 79.23K |
| Q4 2017 | share | Decrease | -3.51% | -2.88K shares | -611K | $149.86 | 79.25K |
| Q3 2017 | share | Decrease | -3.96% | -3.38K shares | 1.46M | $152.04 | 82.13K |
| Q2 2017 | share | Decrease | -9.09% | -8.55K shares | 735K | $128.87 | 85.52K |
| Q1 2017 | share | Increase | +1.00% | 931 shares | 3.42M | $109.35 | 94.07K |
| Q4 2016 | share | Increase | +33.26% | 23.24K shares | 766K | $73.67 | 93.14K |
| Q3 2016 | share | Increase | +10.54% | 6.66K shares | 657K | $87.21 | 69.89K |
| Q2 2016 | share | Decrease | -2.50% | -1.62K shares | 284K | $86.02 | 63.23K |
| Q1 2016 | share | Increase | +28.47% | 14.37K shares | -1.19M | $79.49 | 64.85K |